# Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas

> **NCT00274755** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 250 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** chemotherapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** magnetic resonance imaging
- **PROCEDURE:** magnetic resonance spectroscopic imaging
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00274755
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2007-04
- **Final completion:** —
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2014-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274755, "Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00274755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*